Extensive sacral hidradenitis suppurativa: Yaygın sakral hidradenitis suppurativa

Hüseyin Yılmaz; Akın Çalışır; İlhan Ece; Fahrettin Acar; Mustafa Şahin

doi:10.5455/GMJ-30-38316

Authors

Hüseyin Yılmaz Selçuk University, Faculty of Medicine, Department of General Surgery, Konya
Akın Çalışır Selçuk University, Faculty of Medicine, Department of General Surgery, Konya
İlhan Ece Selçuk University, Faculty of Medicine, Department of General Surgery, Konya
Fahrettin Acar Selçuk University, Faculty of Medicine, Department of General Surgery, Konya
Mustafa Şahin Selçuk University, Faculty of Medicine, Department of General Surgery, Konya

DOI:

https://doi.org/10.5455/GMJ-30-38316

Keywords:

Hidradenitis, infection, sacral region

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammation of apocrine sweat glands, and reduces the quality of life of patients and causes many morbidities. The patients often use various antibiotics, retinoids, and immunosuppressive drugs for many years before surgical intervention. The main purpose of surgical treatment is to provide an acceptable disease control and minimize the recurrence rate after surgery. Drainage or local excision methods have very high recurrence rates. In this case, we aimed to present the treatment of extensive sacral HS, with wide excision and bilateral V-Y advancement flap.

Metrics

Metrics Loading ...

References

Slade DE, Powell BW, Mortimer PS. Hidradenitis suppurativa: pathogenesis and management. Br J Plast Surg 2003;56(5):451-61.

Bocchini SF, Habr-Gama A, Kiss DR, Imperiale AR, Araujo SE. Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Dis Colon Rectum 2003:46(7):944-9.

Lirón-Ruiz R, Torralba-Martinez JA, Pellicer-Franco E, Morales-Cuenca G, Martín-Lorenzo JG, Miguel-Perelló J, et al. Treatment of long-standing extensive perianal hidradenitis suppurativa using double rotation plasty, V-Y plasty and free grafts. Int J Colorectal Dis 2004;19(1):73-8.

Jemec GBE, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996;35(2 Pt 1):191-4.

Mitchell KM, Beck DE. Hidradenitis suppurativa. Surg Clin North Am 2002;82(6):1187-97.

Watson JD. Hidradenitis suppurativa: a clinical review. Br J Plast Surg 1985;38(4):567-9.

Mortimer PS, Dawber RP, Gales MA, Moore RA. A doubleblind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 1986;115(3):263-8.

Shah N. Hidradenitis suppurativa: a treatment challenge. Am Fam Physician 2005;72(8):1547-52.

Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom JW. The differential diagnosis and comorbidity of hidradenitis suppurativa and perianal Crohn’s disease. Int J Colorectal Dis 1993;8(3):117-9.

Wiltz O, Schoetz DJ Jr, Murray JJ, Roberts PL, Coller JA, Veidenheimer MC. Perianal hidradenitis suppurativa. The Lahey Clinic experience. Dis Colon Rectum 1990;33(9):731- 4.

Jansen I, Altmeyer P, Piewig G. Acne inversa (alias hidradenitis suppurativa), J Eur Acad Dermatol Venereol 2001;15(6):532-40.

Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, et al. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 2009;219(2):148-54.

Von der Werth JM, Williams HC. The natural history of hidradenitis suppurativa. J Eur Acad Dermatol Venerol 2000;14(5):389-92.

Ritz P, Runkel N, Haier J, Buhr HJ. Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis 1998;13(4):164-8.

Grischkan D, Steiger E, Fazio V. Maintenance of home hyperalimentation in patients with high-output jejunostomies. Arch Surg 1979;114(7):838-41.